Our data also showed that KDM4A expression levels were higher in cells from AML patients, and the expression levels of KDM4B and KDM4C were comparable between AML patients and normal hematopoietic mononuclear cells from cord blood (Figure 1B). This evidence concerns the gene KDM4B and acute myeloid leukemia.